We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+11.27%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$15.6M
Cap. Flow
+$220M
Cap. Flow %
163.5%
Top 10 Hldgs %
31.52%
Holding
253
New
80
Increased
47
Reduced
36
Closed
74

Top Buys

1
HUM icon
Humana
HUM
+$4.21M
2
AMGN icon
Amgen
AMGN
+$3.4M
3
EHC icon
Encompass Health
EHC
+$3.34M
4
SLNO
Soleno Therapeutics
SLNO
+$3.29M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.9M

Top Sells

1
CNC icon
Centene
CNC
+$10.3M
2
UNH icon
UnitedHealth
UNH
+$4.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$3M
5
CON
Concentra Group Holdings
CON
+$2.39M

Sector Composition

1 Healthcare 51.79%
2 Financials 16.59%
3 Materials 5%
4 Technology 2.34%
5 Energy 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBIT icon
1
iShares Bitcoin Trust
IBIT
$47B
$5.94M 4.4%
97,000
-53,623
-36% -$3M
CAPR icon
2
PUT
Capricor Therapeutics
CAPR
$1.13B
$5.48M 4.06%
+65,650
New +$693K
SLNO
3
DELISTED
Soleno Therapeutics
SLNO
$5.47M 4.06%
65,319
+43,898
+205% +$3.29M
HUM icon
4
Humana
HUM
$48B
$4.91M 3.64%
20,069
+16,899
+533% +$4.21M
PNTG icon
5
Pennant Group
PNTG
$1.46B
$4.18M 3.1%
139,906
-29,303
-17% -$804K
EHC icon
6
Encompass Health
EHC
$11.1B
$3.58M 2.66%
+29,226
New +$3.34M
AMGN icon
7
Amgen
AMGN
$198B
$3.35M 2.49%
+12,000
New +$3.4M
CORT icon
8
PUT
Corcept Therapeutics
CORT
$9.72B
$3.31M 2.46%
128,368
+128,022
+37,001% +$9.28M
ALHC icon
9
Alignment Healthcare
ALHC
$4.26B
$3.19M 2.37%
227,889
-36,066
-14% -$581K
TGTX icon
10
TG Therapeutics
TGTX
$8.4B
$3.08M 2.28%
85,580
+49,508
+137% +$1.84M
NBIX icon
11
Neurocrine Biosciences
NBIX
$17.2B
$2.72M 2.02%
21,625
+7,321
+51% +$840K
LLY icon
12
Eli Lilly
LLY
$1.05T
$2.65M 1.97%
3,404
-1,084
-24% -$842K
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$15.5B
$2.55M 1.89%
24,028
+4,004
+20% +$435K
BMRN icon
14
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.43M 1.8%
44,264
+32,181
+266% +$1.9M
CAH icon
15
Cardinal Health
CAH
$53.5B
$2.28M 1.69%
13,598
-1,144
-8% -$170K
THC icon
16
Tenet Healthcare
THC
$16.8B
$2.2M 1.63%
+12,521
New +$1.88M
EHAB
17
DELISTED
Enhabit
EHAB
$1.99M 1.47%
205,983
-81,140
-28% -$749K
NXE icon
18
NexGen Energy
NXE
$5.82B
$1.93M 1.43%
278,082
+19,443
+8% +$110K
CNOB icon
19
Center Bancorp
CNOB
$1.68B
$1.89M 1.41%
81,814
-2,358
-3% -$53.8K
PINC
20
DELISTED
Premier
PINC
$1.79M 1.33%
+81,593
New +$1.76M
EVH icon
21
Evolent Health
EVH
$652M
$1.75M 1.3%
+155,729
New +$1.43M
ETHA
22
iShares Ethereum Trust ETF
ETHA
$5.09B
$1.64M 1.22%
+85,897
New +$1.43M
CCB icon
23
Coastal Financial
CCB
$1.2B
$1.59M 1.18%
16,432
-5,382
-25% -$464K
MLTX icon
24
PUT
MoonLake Immunotherapeutics
MLTX
$1.65B
$1.48M 1.1%
+45,499
New +$1.85M
PCVX icon
25
Vaxcyte
PCVX
$8.12B
$1.48M 1.1%
45,499
+24,360
+115% +$799K
1
2 3 4 5

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Persistent Asset Partners held 253 positions worth $135M, up 13% from $119M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Persistent Asset Partners deployed $220M of net new capital in Q2 2025, opening 80 new positions and adding to 47 existing holdings. Its largest new stake was Amgen: 12,000 shares worth $3.35M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 61% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $3.17M trimmed.

  • Persistent Asset Partners's largest Q2 2025 buy was Amgen: 12,000 shares worth $3.35M.
  • Persistent Asset Partners added most to Humana in Q2 2025, an estimated $4.21M increase.
  • Persistent Asset Partners's biggest Q2 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $3.17M.
  • Persistent Asset Partners fully exited Centene in Q2 2025, selling an estimated $10.3M.
  • Persistent Asset Partners's ten largest holdings make up 32% of its $135M portfolio in Q2 2025.
  • Persistent Asset Partners opened 80 new positions and closed 74 in Q2 2025.
  • Persistent Asset Partners's portfolio value rose 13% quarter-over-quarter to $135M.

Based on Persistent Asset Partners's 13F filing for Q2 2025, filed 11 Aug 2025.